Literature DB >> 908348

Studies on the toxicity and antitumour activity of prednimustine, a prednisolone ester of chlorambucil.

K R Harrap, P G Riches, E D Gilby, S M Sellwood, R Wilkinson, I Konyves.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1977        PMID： 908348     DOI： 10.1016/0014-2964(77)90143-8

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN： 0014-2964            Impact factor:   9.162


× No keyword cloud information.
  16 in total

1.  Studies on the pharmacokinetics of chlorambucil and prednimustine in patients using a new high-performance liquid chromatographic assay.

Authors:  M M Oppitz; E Musch; M Malek; H P Rüb; G E von Unruh; U Loos; B Mühlenbruch
Journal:  Cancer Chemother Pharmacol       Date:  1989       Impact factor: 3.333

Review 2.  New cancer chemotherapy drugs in Europe.

Authors:  G Mathé; L M van Putten
Journal:  Cancer Chemother Pharmacol       Date:  1978       Impact factor: 3.333

3.  Prednimustine in combination with methotrexate and 5-fluorouracil in advanced breast cancer: a phase I-II study.

Authors:  H T Mouridsen; E Boesen
Journal:  Breast Cancer Res Treat       Date:  1983       Impact factor: 4.872

4.  Phase II trial of prednimustine (NSC-134087) in the treatment of small-cell anaplastic carcinoma of the lung.

Authors:  H S Jensen; H H Hansen; P Dombernowsky
Journal:  Cancer Chemother Pharmacol       Date:  1980       Impact factor: 3.333

5.  The pharmacokinetics of prednimustine and chlorambucil in the rat.

Authors:  D R Newell; C R Shepherd; K R Harrap
Journal:  Cancer Chemother Pharmacol       Date:  1981       Impact factor: 3.333

6.  Cellular kinetics of prednimustine versus chlorambucil plus prednisolone in vitro.

Authors:  E Musch; M Malek; J Peter-Katalinic; H Egge; H Rink; B Lathan; E Riedel
Journal:  Cancer Chemother Pharmacol       Date:  1992       Impact factor: 3.333

7.  Cytotoxicity and metabolism of prednimustine, chlorambucil and prednisolone in a Chinese hamster cell line.

Authors:  B Hartley-Asp; P O Gunnarsson; J Liljekvist
Journal:  Cancer Chemother Pharmacol       Date:  1986       Impact factor: 3.333

8.  Treatment of refractory chronic lymphocytic leukemia with prednimustine: a phase II study using strict response criteria.

Authors:  D R Gandara; C B George; C A Ries; M M Koretz; J P Lewis
Journal:  Cancer Chemother Pharmacol       Date:  1987       Impact factor: 3.333

9.  Mitozantrone and prednimustine in the treatment of advanced breast cancer--a toxic regimen with low activity.

Authors:  M E O'Brien; D M Eccles; S G Allen; G Knight; A Rodger; U Chetty; J F Smyth; R C Leonard
Journal:  Cancer Chemother Pharmacol       Date:  1991       Impact factor: 3.333

10.  Randomised trial comparing prednimustine with combination chemotherapy in advanced ovarian carcinoma.

Authors:  R C Leonard; G E Smart; J R Livingstone; M A Cornbleet; G R Kerr; S Fletcher; J N Webb; J F Smyth
Journal:  Cancer Chemother Pharmacol       Date:  1989       Impact factor: 3.333
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.